Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Orange

Showing results (71-80 of 357) with videos related to

Pageof 36
Sort By:
The Journal of Experimental Medicine|October 1, 1995
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administrationJ S Orange, B Wang, C Terhorst, et al.
Frontiers in Immunology|June 8, 2017
Specific Antibody Deficiency: Controversies in Diagnosis and ManagementElena Perez, Francisco A Bonilla, Jordan S Orange, et al.
Journal of Clinical Immunology|December 17, 2013
Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulinJeffrey S Stonebraker, Albert Farrugia, Benjamin Gathmann, et al.
Current Opinion in Pediatrics|October 20, 2021
New primary immunodeficiencies 2021 context and futureYesim Demirdag, Ramsay Fuleihan, Jordan S Orange, et al.
Nature Communications|July 21, 2016
Human NK cell development requires CD56-mediated motility and formation of the developmental synapseEmily M Mace, Justin T Gunesch, Amera Dixon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 3, 2011
Eosinophilic fasciitis mimicking angioedema and treatment response to infliximab in a pediatric patientNina Poliak, Jordan S Orange, Bruce R Pawel, et al.
Cell Cycle (Georgetown, Tex.)|September 23, 2009
Chipping away at gamma-H2AX fociVelibor Savic, Keri B Sanborn, Jordan S Orange, et al.
American Health & Drug Benefits|June 20, 2017
Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization AlgorithmJordan S Orange, Matt Johnson, Barb Lennert, et al.
Cellular and Molecular Life Sciences : CMLS|September 21, 2004
The Wiskott-Aldrich syndromeJ S Orange, K D Stone, S E Turvey, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 25, 2013
Immunodeficiency in patients with 49,XXXXY chromosomal variationMichael D Keller, Teresa Sadeghin, Carole Samango-Sprouse, et al.
Pageof 36

Showing results (71-80 of 357) with videos related to

Sort By:
Pageof 36
The Journal of Experimental Medicine|October 1, 1995
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administrationJ S Orange, B Wang, C Terhorst, et al.
Frontiers in Immunology|June 8, 2017
Specific Antibody Deficiency: Controversies in Diagnosis and ManagementElena Perez, Francisco A Bonilla, Jordan S Orange, et al.
Journal of Clinical Immunology|December 17, 2013
Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulinJeffrey S Stonebraker, Albert Farrugia, Benjamin Gathmann, et al.
Current Opinion in Pediatrics|October 20, 2021
New primary immunodeficiencies 2021 context and futureYesim Demirdag, Ramsay Fuleihan, Jordan S Orange, et al.
Nature Communications|July 21, 2016
Human NK cell development requires CD56-mediated motility and formation of the developmental synapseEmily M Mace, Justin T Gunesch, Amera Dixon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 3, 2011
Eosinophilic fasciitis mimicking angioedema and treatment response to infliximab in a pediatric patientNina Poliak, Jordan S Orange, Bruce R Pawel, et al.
Cell Cycle (Georgetown, Tex.)|September 23, 2009
Chipping away at gamma-H2AX fociVelibor Savic, Keri B Sanborn, Jordan S Orange, et al.
American Health & Drug Benefits|June 20, 2017
Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization AlgorithmJordan S Orange, Matt Johnson, Barb Lennert, et al.
Cellular and Molecular Life Sciences : CMLS|September 21, 2004
The Wiskott-Aldrich syndromeJ S Orange, K D Stone, S E Turvey, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 25, 2013
Immunodeficiency in patients with 49,XXXXY chromosomal variationMichael D Keller, Teresa Sadeghin, Carole Samango-Sprouse, et al.
Pageof 36